UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
151.16
-6.17 (-3.92%)
Jan 28, 2026, 4:00 PM EST
UCB SA Revenue
UCB SA had revenue of 3.49B EUR in the half year ending June 30, 2025, with 38.43% growth. This brings the company's revenue in the last twelve months to 6.85B, up 25.56% year-over-year. In the year 2024, UCB SA had annual revenue of 6.15B with 18.72% growth.
Revenue (ttm)
6.85B EUR
Revenue Growth
+25.56%
P/S Ratio
7.13
Revenue / Employee
796.28K EUR
Employees
8,600
Market Cap
57.35B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.15B | 970.00M | 18.72% |
| Dec 31, 2023 | 5.18B | -265.00M | -4.87% |
| Dec 31, 2022 | 5.45B | -330.00M | -5.71% |
| Dec 31, 2021 | 5.78B | 430.00M | 8.04% |
| Dec 31, 2020 | 5.35B | 434.00M | 8.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 292.21M |
| Vaxart | 148.20M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
| Northwest Biotherapeutics | 937.00K |
| Arch Biopartners | -62.11K |
UCB SA News
- 3 days ago - UCB Breaks Above 3% Yield Territory - Nasdaq
- 5 days ago - Insider Sell: Alan Kumler Sells Shares of United Community Banks Inc (UCB) - GuruFocus
- 9 days ago - HARBOR CAPITAL ADVISORS, INC. Buys 2,889 Shares of United Community Banks Inc (UCB) - GuruFocus
- 13 days ago - Best Momentum Stocks to Buy for Jan. 16 - Nasdaq
- 13 days ago - Best Income Stocks to Buy for Jan. 16 - Nasdaq
- 14 days ago - United Community Banks UCB Earnings Transcript - The Motley Fool
- 14 days ago - Keefe, Bruyette & Woods Maintains UCB Rating, Raises Price Target | UCB Stock News - GuruFocus
- 15 days ago - United Community Banks Is Inching Toward An Upgrade - Seeking Alpha